I
ImpriMed
0 followers
ImpriMed provides cutting-edge personalized medicine easily accessible for pets with blood cancer diseases.
Org chart
Sungwon Lim
Co-Founder & CEO
Sungwon Lim
Collapse
Jamin Koo
Co-Founder & Director
Mary Ocnean
VP, Commercial Operations
Ilona Holcomb
Director, Bioscience
Rachel Venable
Medical Oncology Consultant
Kalyn Concepcion
Laboratory Technician
Board & advisors
Douglas H. Thamm
Advisor
Wendi Velando Rankin
Advisor
Carlos Bustamante
Advisor
Sean McDonald
Board
Jinjoo Kim
Director
Tariq Shah
Business Consultant
Kevin Choy
Medical Consultant
Robert Barthel
Veterinary Science Consultant